Fresh from a win in New Jersey state court, Merck & Co. returns to Texas for the first federal trial of a Vioxx case, just 45 miles north of where a Texas state court jury handed the first Vioxx plaintiffs a $253 million verdict last summer. Some legal observers say that stricter federal rules and procedures involving the admission of evidence, jury selection and what lawyers can say in front of a jury give Merck the advantage in the trial, scheduled to begin today.
Vioxx Litigation Goes Federal
The National Law Journal
November 29, 2005
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.